Impact of kidney transplantation on aortic stiffness and aortic stiffness index β0

Marie-Pier Desjardins1, Aboubacar Sidibé1, Catherine Fortier1

  • 1CHU de Québec Research Center, Hotel-Dieu de Québec Hospital, Division of Nephrology, Université Laval, Québec, Québec City, Canada.

Journal of Hypertension
|February 13, 2019
PubMed

Insights

Kidney transplantation initially reduces aortic stiffness but later increases it, linked to immune system activation. This study tracked aortic stiffness changes post-transplant to understand long-term arterial health.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Immunology

Background:

  • Enhanced aortic stiffness in chronic kidney disease (CKD) elevates cardiovascular event risk.
  • Kidney transplantation (KTx) may improve aortic stiffness, but the role of blood pressure reduction versus intrinsic arterial changes is unclear.
  • Long-term effects of KTx on aortic stiffness are uncertain due to potential immune system impacts.

Purpose of the Study:

  • To assess early and late changes in aortic stiffness after KTx, independent of blood pressure.
  • To identify patient characteristics associated with favorable and unfavorable long-term aortic stiffness trajectories.
  • To investigate the relationship between immune markers and aortic stiffness changes post-KTx.

Main Methods:

  • Longitudinal study of 79 individuals undergoing KTx.
  • Aortic stiffness assessed via carotid-femoral pulse wave velocity (cf-PWV) at baseline, 3, 6, and 24 months post-KTx.
  • Aortic stiffness index β0 used as a blood pressure-independent parameter, with statistical adjustments for blood pressure.

Main Results:

  • Aortic stiffness index β0 initially decreased at 3 months post-KTx.
  • A significant increase in β0 was observed at 6 and 24 months compared to the 3-month mark.
  • Late stiffening was associated with elevated interleukin-6 levels, even after adjusting for confounders.

Conclusions:

  • KTx initially improves intrinsic aortic mechanical properties (de-stiffening).
  • A subsequent stiffening phase occurs, potentially driven by immune system activation.
  • Interleukin-6 elevation suggests a role for immune-mediated arterial wall remodeling in kidney recipients.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
597
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
437
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
433
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
311
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
401
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
505